Shandong Pharmaceutical Glass Co Ltd (600529) — Cash Flow Quality Index
Shandong Pharmaceutical Glass Co Ltd (600529) has a Cash Flow Quality Index of 0.28x as of December 2025. Operating cash flow of CN¥41.46 Million is below net income of CN¥147.17 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Shandong Pharmaceutical Glass Co Ltd (600529) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Pharmaceutical Glass Co Ltd Cash Flow Quality Index (2001–2025)
Historical Cash Flow Quality Index for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Pharmaceutical Glass Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Year-by-year earnings quality comparison for Shandong Pharmaceutical Glass Co Ltd. For live market cap and the full company financial profile, see Shandong Pharmaceutical Glass Co Ltd (600529) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | CN¥576.92 Million | CN¥689.63 Million | ▼ -32.3% |
| 2024 | 1.24x | CN¥1.17 Billion | CN¥942.99 Million | ▼ -8.5% |
| 2023 | 1.35x | CN¥1.05 Billion | CN¥775.80 Million | ▲ +230.9% |
| 2022 | 0.41x | CN¥252.44 Million | CN¥618.29 Million | ▼ -67.8% |
| 2021 | 1.27x | CN¥750.44 Million | CN¥591.09 Million | ▲ +26.6% |
| 2020 | 1.00x | CN¥566.01 Million | CN¥564.44 Million | ▼ -23.2% |
| 2019 | 1.31x | CN¥599.05 Million | CN¥458.69 Million | ▲ +0.4% |
| 2018 | 1.30x | CN¥465.77 Million | CN¥358.21 Million | ▼ -17.1% |
| 2017 | 1.57x | CN¥411.96 Million | CN¥262.76 Million | ▼ -41.5% |
| 2016 | 2.68x | CN¥506.53 Million | CN¥189.05 Million | ▼ -0.5% |
| 2015 | 2.69x | CN¥389.63 Million | CN¥144.67 Million | ▲ +24.9% |
| 2014 | 2.16x | CN¥266.63 Million | CN¥123.64 Million | ▼ -1.8% |
| 2013 | 2.20x | CN¥268.60 Million | CN¥122.33 Million | ▲ +822.5% |
| 2012 | 0.24x | CN¥28.52 Million | CN¥119.83 Million | ▼ -88.5% |
| 2011 | 2.07x | CN¥274.63 Million | CN¥132.51 Million | ▲ +64.2% |
| 2010 | 1.26x | CN¥217.01 Million | CN¥171.97 Million | ▼ -26.7% |
| 2009 | 1.72x | CN¥249.27 Million | CN¥144.84 Million | ▲ +166.5% |
| 2008 | 0.65x | CN¥91.76 Million | CN¥142.06 Million | ▼ -41.3% |
| 2007 | 1.10x | CN¥122.63 Million | CN¥111.53 Million | ▲ +32.0% |
| 2006 | 0.83x | CN¥78.47 Million | CN¥94.18 Million | ▲ +56.5% |
| 2005 | 0.53x | CN¥44.09 Million | CN¥82.79 Million | ▲ +1193.8% |
| 2004 | -0.05x | CN¥-3.70 Million | CN¥75.98 Million | ▼ -105.8% |
| 2003 | 0.84x | CN¥59.35 Million | CN¥70.71 Million | ▼ -55.7% |
| 2002 | 1.89x | CN¥109.26 Million | CN¥57.72 Million | ▲ +172.6% |
| 2001 | 0.69x | CN¥28.60 Million | CN¥41.20 Million | — |